Challenges of ophthalmic care in the developingworld

JAMA Ophthalmology

Volumn 132, Issue 5, 2014, Pages 640-644

  Sommer, Alfred ^a,b   Taylor, Hugh R ^c   Ravilla, Thulasiraj D ^d   West, Sheila ^a,b   Lietman, Thomas M ^e   Keenan, Jeremy D ^e   Chiang, Michael F ^f,g   Robin, Alan L ^a   Mills, Richard P ^h  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ARAVIND EYE CARE SYSTEM   (India)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; CATARACT; CORNEA DISEASE; CYTOMEGALOVIRUS RETINITIS; DEVELOPING COUNTRY; EYE CARE; EYE DISEASE; HUMAN; KERATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; REVIEW; SYMPOSIUM; TRACHOMA;

BLINDNESS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HUMANS; OPHTHALMOLOGY; WORLD HEALTH;

EID: 84900406285     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.84     Document Type: Review

References (29)

1. World Health Organization. State of theWorld's Sight:VISION 2020: the Right to Sight: 1999-2005. 2005. http://www.who.int/pbd/blindness/vision-2020/ v2020-therighttosight.pdf.Accessed April 30, 2013.
2. Lewallen S, Thulasiraj RD. Eliminating cataract blindness: how do we apply lessons from Asia to sub-Saharan Africa? Glob Public Health. 2010;5(6):639-648.
3. Rao GN, Khanna RC, Athota SM, Rajshekar V, Rani PK. Integrated model of primary and secondary eye care for underserved rural areas: the L V Prasad Eye Institute experience. Indian J Ophthalmol. 2012;60(5):396-400.
4. Taylor HR. LXIII Edward Jackson Memorial Lecture: eye care: dollars and sense. Am J Ophthalmol. 2007;143(1):1-8.
5. The Fred Hollows Foundation. Investing in Vision. 2013. http://www.hollows.org.au/our-work/the-price-of-sight. Accessed April 30, 2013.
6. Bourne RRA, Stevens GA, White RA, et al. Causes of global vision loss: 1990-2010. Ophthalmology. In press.
7. World Health Organization.World Health Organization Sixty-sixthWorld Health Assembly. 2013. http://www.who.int/mediacentre/events/2013/wha66/en/ index.html. Accessed April 30, 2013.
8. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Brit J Ophthalmol. 2012;96(5):614-618.
9. Courtright P, Ndegwa L, Msosa J, Banzi J. Use of our existing eye care human resources: assessment of the productivity of cataract surgeons trained in eastern Africa. Arch Ophthalmol. 2007;125(5): 684-687.
10. World Health Organization. Informal Consultation on Analysis of Blindness Prevention Outcomes: Geneva, 16-18 February 1998. http://whqlibdoc.who.int/hq/ 1998/WHO-PBL-98 .68.pdf. Accessed June 10, 2013.
11. US Census Bureau. International Data Base: Estimate for 2011.Washington, DC: US Census Bureau.
12. Mariotti SP, PascoliniD, Rose-Nussbaumer J. Trachoma: globalmagnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93(5):563-568.
13. Grayston JT,Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis. 1985;7(6):717-725.
14. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma, II: the importance of repeated reinfection. Invest Ophthalmol Vis Sci. 1982;23(4):507-515.
15. Whitcher JP, Srinivasan M. Corneal ulceration in the developing world: a silent epidemic. Br J Ophthalmol. 1997;81(8):622-623.
16. Lalitha P, Srinivasan M, Manikandan P, et al. Relationship of in vitro susceptibility tomoxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis. 2012;54(10):1381-1387.
17. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130(2):143-150.
18. Srinivasan M, UpadhyayMP, Priyadarsini B, Mahalakshmi R, Whitcher JP. Corneal ulceration in south-east Asia, III: prevention of fungal keratitis at the village level in south India using topical antibiotics. Br J Ophthalmol. 2006;90(12):1472-1475.
19. Holland GN, Shuler JD. Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol. 1992;110(10):1435-1442.
20. Heiden D, Ford N, Wilson D, et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007;4(12):e334.
21. PathanapitoonK,AusayakhunS,KunavisarutP,etal. Blindness and lowvision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina. 2007;27(5):635-640.
22. Teoh SC, Ou X, Lim TH. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen. Ophthalmology. 2012;119(3):588-595.
23. Rachapelle S, Legood R, Alavi Y, et al. The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology. 2013;120(3):566-573.
24. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia, I: nursery observations. Am J Ophthalmol. 1952;35(9):1248-1253.
25. CarloWA, Finer NN,Walsh MC, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362(21):1959-1969.
26. Gilbert C, Fielder A, Gordillo L, et al; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-e525.
27. Richter GM, Williams SL, Starren J, Flynn JT, ChiangMF. Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Surv Ophthalmol. 2009;54(6):671-685.
28. Paul Chan RV,Williams SL, Yonekawa Y, Weissgold DJ, Lee TC, ChiangMF. Accuracy of retinopathy of prematurity diagnosis by retinal fellows. Retina. 2010;30(6):958-965.
29. Brown AS, Ostmo S, Fink C, et al. Armenian ROP EyeCare Project: agreement between ophthalmoscopic diagnosis by newly trained local ophthalmologists vs remote image-based diagnosis by experts. Invest Ophthalmol Vis Sci. 2013;44. ARVO e-Abstract 599.